SCHEMBL26880969

SCHEMBL26880969

Cc1c2c(c3ocnc3c1C(C)(C)C)OC(C)(C(C)(C)C)O2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26880967 0.74 MEN1 (0.31) —
SCHEMBL26880963 0.74 — —
SCHEMBL26880954 0.73 — —
SCHEMBL26880964 0.71 — —
SCHEMBL26880965 0.71 MEN1 (0.31) —
SCHEMBL26880959 0.70 — —
SCHEMBL23823303 0.68 — —
SCHEMBL26880968 0.68 — —
SCHEMBL26880971 0.66 HTT (0.31) —
SCHEMBL26880958 0.64 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365541-A1 INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-11-16 — — US disclosed
US-20230365541-A1 INHIBITOR OF ENHANCER OF ZESTE HOMOLOGUE 2, AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2023-11-16 — — US disclosed
Send feedback